期刊
PHYTOTHERAPY RESEARCH
卷 27, 期 3, 页码 374-379出版社
WILEY
DOI: 10.1002/ptr.4715
关键词
obesity; hyperlipidemia; triglyceride; cholesterol; cardiovascular disease; C-reactive protein; body mass index
资金
- Mashhad University of Medical Science (MUMS), Mashhad, Iran
Dyslipidemia is a leading risk factor for cardiovascular disease and is also a common feature of obesity. Curcumin is a bioactive phytochemical with well-known antioxidant, anti-inflammatory, and cardioprotective properties. The present study investigated the hypolipidemic activity of curcumin in obese individuals. Participants (n=30) were treated with curcuminoids (1g/day), or placebo in a randomized, double-blind, placebo-controlled, crossover trial. Serum concentrations of total cholesterol, triglycerides, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol, together with anthropometric parameters and high-sensitivity C-reactive protein were measured before and after each treatment period. Anthropometric parameters including weight, BMI, waist circumference, hip circumference, arm circumference, and body fat remained statistically unchanged by the end of trial (p>0.05). As for the lipid profile parameters, serum triglycerides were significantly reduced following curcumin supplementation (p=0.009). However, curcuminoids were not found to affect serum levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and high-sensitivity C-reactive protein (p>0.05). In summary, the findings of the present study indicated that curcuminoid supplementation (1g/day for 30days) leads to a significant reduction in serum triglycerides concentrations but do not have a significant influence on other lipid profile parameters as well as body mass index and body fat. Copyright (c) 2012 John Wiley & Sons, Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据